Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grant R Wilkinson

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|May 27, 2005
Drug metabolism and variability among patients in drug responseGrant R Wilkinson
Clinical Pharmacology and Therapeutics|August 4, 2004
Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questionsGrant R Wilkinson
Clinical Pharmacology and Therapeutics|October 8, 2004
In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolamAndrew L Masica, Gail Mayo, Grant R Wilkinson
Clinical Pharmacology and Therapeutics|April 30, 2004
CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differencesHarumi Takahashi, Grant R Wilkinson, Roberto Padrini, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activityDaniel Kurnik, Alastair J J Wood, Grant R Wilkinson
Clinical Pharmacology and Therapeutics|September 18, 2002
Cytochrome P450 2E1 and 3A activities do not differ between Mexicans and European AmericansRussell A Poland, Keh-Ming Lin, Cenci Nuccio, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjectsGeorge K Dresser, Ute I Schwarz, Grant R Wilkinson, et al.
Pharmacogenomics|April 23, 2004
Genetic variability in CYP3A5 and its possible consequencesHong-Guang Xie, Alastair J J Wood, Richard B Kim, et al.
Inorganic Chemistry|May 23, 2025
Bis(<i>tert</i>-butoxydiphenylsilyl)amide Divalent Lanthanide ComplexesGrant R Wilkinson, Sarah J Schultz, Kaitlyn S Otte, et al.
Blood|April 9, 2004
5'-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patientsHarumi Takahashi, Ichiro Ieiri, Grant R Wilkinson, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|May 27, 2005
Drug metabolism and variability among patients in drug responseGrant R Wilkinson
Clinical Pharmacology and Therapeutics|August 4, 2004
Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questionsGrant R Wilkinson
Clinical Pharmacology and Therapeutics|October 8, 2004
In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolamAndrew L Masica, Gail Mayo, Grant R Wilkinson
Clinical Pharmacology and Therapeutics|April 30, 2004
CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differencesHarumi Takahashi, Grant R Wilkinson, Roberto Padrini, et al.
Clinical Pharmacology and Therapeutics|September 6, 2006
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activityDaniel Kurnik, Alastair J J Wood, Grant R Wilkinson
Clinical Pharmacology and Therapeutics|September 18, 2002
Cytochrome P450 2E1 and 3A activities do not differ between Mexicans and European AmericansRussell A Poland, Keh-Ming Lin, Cenci Nuccio, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjectsGeorge K Dresser, Ute I Schwarz, Grant R Wilkinson, et al.
Pharmacogenomics|April 23, 2004
Genetic variability in CYP3A5 and its possible consequencesHong-Guang Xie, Alastair J J Wood, Richard B Kim, et al.
Inorganic Chemistry|May 23, 2025
Bis(<i>tert</i>-butoxydiphenylsilyl)amide Divalent Lanthanide ComplexesGrant R Wilkinson, Sarah J Schultz, Kaitlyn S Otte, et al.
Blood|April 9, 2004
5'-Flanking region polymorphisms of CYP2C9 and their relationship to S-warfarin metabolism in white and Japanese patientsHarumi Takahashi, Ichiro Ieiri, Grant R Wilkinson, et al.
Pageof 4